Institutional Ownership Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM). We have compiled data on the 414 institutions that hold shares in the stock, with a total of 36.8 Million shares, which have been reported (via 13F filing form) to have a value of $5.14 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
82,791
shares
|
$11.6 Million
0.04% of portfolio
|
Q3 2024
Reduced 16.07%
|
|
|
Morgan Jess S & CO Inc
|
Oct 21, 2022 Q3 2022 |
78,895
shares
|
$11 Million
3.06% of portfolio
|
Q3 2022
Reduced 24.78%
|
|
|
Summit Financial, LLC
Parsippany, NJ |
Nov 14, 2025 Q3 2025 |
77,540
shares
|
$10.8 Million
0.16% of portfolio
|
Q3 2025
New holding
|
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
73,000
shares
|
$10.2 Million
4.5% of portfolio
|
Q3 2022
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
72,067
shares
|
$10.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 26.08%
|
|
|
Universal Beteiligungs Und Servicegesellschaft Mb H
Frankfurt Am Main, 2M |
Oct 30, 2025 Q3 2025 |
67,902
shares
|
$9.49 Million
0.01% of portfolio
|
Q3 2025
Added 30.66%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 13, 2025 Q3 2025 |
66,800
shares
|
$9.33 Million
0.0% of portfolio
|
Q3 2025
Added 9.51%
|
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 30, 2025 Q3 2025 |
65,505
shares
|
$9.15 Million
0.46% of portfolio
|
Q3 2025
Added 2.46%
|
|
|
Spider Rock Advisors, LLC
|
Nov 01, 2024 Q3 2024 |
65,008
shares
|
$9.08 Million
0.09% of portfolio
|
Q3 2024
Reduced 7.14%
|
|
|
Peregrine Capital Management LLC
|
Oct 23, 2025 Q3 2025 |
64,521
shares
|
$9.01 Million
0.25% of portfolio
|
Q3 2025
Reduced 12.18%
|
|
|
Canada Pension Plan Investment Board
Toronto Ontario, A6 |
Nov 13, 2025 Q3 2025 |
64,400
shares
|
$9 Million
0.01% of portfolio
|
Q3 2025
Reduced 10.93%
|
|
|
Ifp Advisors, Inc
|
Dec 02, 2025 Q3 2025 |
63,284
shares
|
$8.84 Million
0.21% of portfolio
|
Q3 2025
Reduced 1.15%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
63,065
shares
|
$8.81 Million
0.0% of portfolio
|
Q3 2025
Added 37.15%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
60,778
shares
|
$8.49 Million
0.01% of portfolio
|
Q3 2025
Reduced 1.66%
|
|
|
Scout Investments, Inc.
|
Nov 12, 2024 Q3 2024 |
59,878
shares
|
$8.36 Million
0.16% of portfolio
|
Q3 2024
Reduced 13.92%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
58,300
shares
|
$8.14 Million
1.38% of portfolio
|
Q2 2023
New holding
|
|
|
Clearbridge Investments, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
57,667
shares
|
$8.06 Million
0.01% of portfolio
|
Q3 2025
Added 2.4%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 03, 2025 Q3 2025 |
57,285
shares
|
$8 Million
0.01% of portfolio
|
Q3 2025
Added 1.45%
|
|
|
High Tower Advisors, LLC
Chicago, IL |
Nov 06, 2025 Q3 2025 |
57,115
shares
|
$7.98 Million
0.01% of portfolio
|
Q3 2025
Added 421.03%
|
|
|
Royce & Associates LP
|
Nov 12, 2025 Q3 2025 |
56,036
shares
|
$7.83 Million
0.07% of portfolio
|
Q3 2025
Added 117.56%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
55,273
shares
|
$7.72 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.77%
|
|
|
Privium Fund Management B.V.
|
Nov 03, 2025 Q3 2025 |
52,732
shares
|
$7.37 Million
1.16% of portfolio
|
Q1 2025
Reduced 15.27%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Nov 14, 2025 Q3 2025 |
52,335
shares
|
$7.31 Million
0.14% of portfolio
|
Q3 2025
Reduced 6.96%
|
|
|
Moody Aldrich Partners LLC
|
Oct 20, 2025 Q3 2025 |
51,476
shares
|
$7.19 Million
1.31% of portfolio
|
Q3 2025
Reduced 16.18%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
50,246
shares
|
$7.02 Million
0.0% of portfolio
|
Q3 2025
Reduced 52.61%
|
|